Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 2.910
+0.030 (1.04%)
At close: Mar 6, 2026
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 1.44 billion as of March 6, 2026. Its market cap has increased by 252.87% in one year.
Market Cap
1.44B
Enterprise Value
1.47B
Revenue
12.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.91
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 1.44B, a decrease of -81.92%. That is a compound annual growth rate of -25.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.44B | 48.47% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.98B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Zhaoke Ophthalmology | 1.85B |
| Cutia Therapeutics | 1.71B |
| Mabpharm | 1.67B |
| Immunotech Biopharm | 1.45B |
| CANbridge Pharmaceuticals | 1.39B |
| HighTide Therapeutics | 1.37B |